74 MRSA (Community-Associated)

Saturday, March 20, 2010: 12:30 PM-2:00 PM
Grand Hall (Hyatt Regency Atlanta)
Type: Poster
494
Microbiologic Characteristics of Methicillin-resistant Staphylococcus aureus (MRSA) Bacteremia in a Large Urban Hospital
Emily RM Sydnor, MD, Johns Hopkins University School of Medicine; Tsigereda Tekle, MT, Johns Hopkins Hospital; Paul Stamper, Johns Hopkins University School of Medicine; Karen C. Carroll, MD, Johns Hopkins Hospital; Pranita D. Tamma, MD, Johns Hopkins University; Sara E. Cosgrove, MD, MS, The Johns Hopkins Hospital
495
Birds of a Feather? Hospital-level predictors of community-associated versus hospital-associated methicillin-resistant Staphylococcus aureus (CA-MRSA vs. HA-MRSA) colonization among intensive care unit (ICU) patients
Rosie D. Lyles, MD, MS, John H. Stroger, Jr. Hospital of Cook County; Karen Lolans, B.S., Rush University Medical Center; Mary K. Hayden, MD, Rush University Medical Center; Stephen G. Weber, MD, MSc, University of Chicago Medical Center; Robert A. Weinstein, MD, John H. Stroger, Jr. Hospital of Cook County and Rush University Medical Center; William E. Trick, MD, John H. Stroger, Jr. Hospital of Cook County; Michael Y. Lin, MD, MPH, Rush University Medical Center
496
Characteristics of Community Staphylococcus aureus Isolates from Patients with Respiratory Illness Winter 2003-09
Gregory E. Fosheim, MPH, Centers for Disease Control and Prevention, Divison of Healthcare Quality Promotion; Jeffrey Hageman, MHS, Centers for Disease Control and Prevention, Divison of Healthcare Quality Promotion; Rachel Gorwitz, MD, MPH, Centers for Disease Control and Prevention; David Lonsway, MMSc, Centers for Disease Control and Prevention, Divison of Healthcare Quality Promotion; Valerie E. Schoonover, BS, Centers for Disease Control and Prevention, Divison of Healthcare Quality Promotion; Brandi M. Limbago, PhD, Division of Healthcare Quality Promotion, CDC
497
Methicillin Resistance is Associated with Increased Mortality, But Not Length of Stay, Among Patients with Community-associated S. aureus Bacteremia
Marin L. Schweizer, PhD, University of Maryland; Jon Furuno, PhD, University of Maryland; Sara Cosgrove, MD, Johns Hopkins School of Medicine; Anthony Harris, MD, MPH, University of Maryland School of Medicine; Kerri Thom, MD, MS, University of Maryland; Hannah R. Day, MS, University of Maryland; Eli N. Perencevich, MD, University of Maryland School of Medicine
499
Preferred Treatment and Prevention Strategies for Recurrent Community-Associated Methicillin-resistant Staphylococcus aureus (CA-MRSA) Skin and Soft-Tissue Infections (SSTIs): A Survey of Adult and Pediatric Providers
Kara Mascitti, University of Pennsylvania School of Medicine; Jeff Gerber, University of Pennsylvania School of Medicine; Theoklis Zaoutis, MD, Children's Hospital of Philadelphia; Todd Barton, University of Pennsylvania School of Medicine; Ebbing Lautenbach, MD, MPH, MSCE, University of Pennsylvania School of Medicine
500
Recovery of Staphylococcus aureus from environmental surfaces in a high school and on playgrounds
Ellen Drake, Cleveland VA; Jennifer L. Cadnum, Cleveland VA Medical Center; Curtis J. Donskey, Cleveland VA Medical Center
502
A Randomized Controlled Trial Evaluating the Efficacy of Three Different Decolonization Regimens in Patients with Community-associated Skin Infections and colonized with Staphylococcus aureus
Bernard C. Camins, MD, MSCR, Washington University School of Medicine; Joseph A. Fritz, MD, Washington University School of Medicine; Emma Epplin, Washington University School of Medicine; Rachel C. Orscheln, MD, Washington University School of Medicine; Gregory A. Storch, MD, Washington University School of Medicine; Michael E. Mullins, Washington University School of Medicine; Brian T. Wessman, MD, Washington University School of Medicine; Stephanie A. Fritz, MD, MSCI, Washington University School of Medicine